| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > It May Be Awhile Before The Meek Inherit The Earth |
|
Digg It - It May Be Awhile Before The Meek Inherit The Earth
In my career I have frequently noticed that persons who move into positions of power and authority, w According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hether in the business or political world, change, and seldom for the better. When I was promoted to ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in an executive level position years ago, my sister-in-law, who belonged to a strong union all of her c lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. areer, told my wife that once I was a vice president I would become an unethical creep. I argued tha here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe t she was biased and that you could keep your perspective and ethics in any position. While I did fi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nd some who retained their values and personality, I was surprised to observe that many people in suc ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc h positions seemed to believe that the position required them to become confrontational, bullying, ra easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tionalizing jerks. They interpreted pressures to grow and be productive to mean they must be more co nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ld, authoritarian, absolute and sometimes downright arrogant. Lisa Takeuchi Cullen, in her column in and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the April 2 issue of Time magazine, implied that there is room for the jerk, the bully, in the workp ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ace, that the success of some explosive personalities such as Steve Jobs can be at least somewhat att ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ributed to their jerkiness. I contend that the success and genius of such persons is in spite of the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ir unpleasantness and not because of it. Throughout history, persons who achieved positions of polit cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ical, religious or business power often exercised that power by emotionally terrorizing their subordi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nates. Nothing was gained other than massaging the leader’s ego. The workplace bully, especially wh t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel en in a position of leadership, always has a negative effect on productivity and morale. Led by exam ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ple, subordinates will be more likely to abuse each other, leading to a hostile environment and a bre y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eding ground for workplace violence. This is ultimately an ethical and moral issue. Workplace jerks . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de should be ashamed of themselves and are best, if they can’t be reformed, weeded out like any noxious elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip and counter-productive influence. Managing by the Golden Rule will always make for the best leaders tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Tie Up Loose Ends or Find Yourself in Knots Cisco: Inching Us Towards True Covergence Changing Careers - How to Transition Intelligently from One Field to Another
|